Netherlands· NL-2ba7bac656aa
Omegaven-Fresenius, emulsie voor infusie
A fettemulsionen product containing docosahexaeenzuur + ei fosfatiden, gezuiverd + eicosapentaeenzuur + glycerol (e 422), registered in Netherlands by Fresenius Kabi Nederland B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Fettemulsionen is registered in 11 of 19 countries.
Countries holding a registration under ATC B05BA02 (fettemulsionen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Fettemulsionen · ATC B05BA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DOCOSAHEXAEENZUUR + EI FOSFATIDEN, GEZUIVERD + EICOSAPENTAEENZUUR + GLYCEROL (E 422)
- Manufacturer
- Fresenius Kabi Nederland B.V.
- Country
- Netherlands (NL)
- ATC code
- B05BA02
- ATC class
- Fettemulsionen
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id23043
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05BA02
Fettemulsionen, as other registers publish it.
- FinlandClinoleicBaxter Oy
- DenmarkClinoleicBaxter A/S
- NorwayClinoleicBaxter Medical AB
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
- CzechiaCLINOLEICBAXTER CZECH spol. s r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5c690aea-9821-4e24-ab24-e29d16f1d83e GET /v1/drugs/5c690aea-9821-4e24-ab24-e29d16f1d83e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsie voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h23043_smpc.pdf",
"strength": null,
"atc_label": "Fat Emulsions",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg23043",
"excipients": [
"NATRIUMHYDROXIDE (E 524)",
"NATRIUMOLEAAT (E 470A)",
"STIKSTOF (HEAD SPACE) (E 941)",
"WATER VOOR INJECTIE"
],
"substances": [
"DOCOSAHEXAEENZUUR",
"EI FOSFATIDEN, GEZUIVERD",
"EICOSAPENTAEENZUUR",
"GLYCEROL (E 422)",
"TOCOFEROL, DL-ALFA (E 307)",
"VISOLIE, HOOG GERAFFINEERD"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h23043.pdf",
"authorised_at": "1999/04/20",
"procedure_number": "DE/H/0139/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "23043",
"additional_monitoring": "N"
}See everything about fettemulsionen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.